A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole

Clinical trial NCT04622358 · COMPLETED

Trial details

NCT number: NCT04622358
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2020-12-05
Primary completion: 2021-03-08
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.